References
- Bahr C. VON, Glaumann H., Mellstrom B., Sjoqvist F. Trends Pharm. Sci., (TIPS) 1982; 487
- Baker M.H., Foster A.B., Hegedus L., Jarman M., Rowlands M.G., Coe P.L., Troth J. Biomed. Mass Spectrom 1984; 11: 512
- Foster A.B. Trends Pharm. Sci., (TIPS) 1984; 524
- Foster A.B. Adv. Drug Res. 1985; 14: 1
- Frommer U., Ullrich V., Staudinger H., Orrenius S. Biochem. Biophys. Acta 1972; 280: 487
- Fry J.R., Bridges J.N. Prog. Drug Metab. 1977; 2: 71
- Hartree E.F. Analyt. Biochem. 1972; 48: 422
- Haszeldine R.N. J. chem. Soc. 1949; 2856
- Hjelmeland L.M., Aronow L., Trudell J.R. Molec. Pharmac. 1977; 13: 634
- Howe I., Williams D.H., Bowen R.D. Mass Spectrometry: Principles and Applications, 2nd ed. McGraw-hill, New York 1981; 134–137
- Idoux J.P., Gupton J.T., McCurrey C.K., Crews A.D., Jurss C.D., Colon C., Rambi R.C. J. org. Chem. 1983; 48: 3771
- Janzowski C., Gottfried J., Pool B.L., Eisenbrand G., Preussman R. I.A.R.C. Sci. Publ. 1982a, 41: 517
- Janzowski C., Pool B.L., Preussman R., Eisenbrand G. Carcinogenesis 1982b; 3: 155
- Kramer A., Staudinger H., Ullrich V. Chem,-Biol. Interact. 1974; 8: 11
- McMahon R.E., Culp H.W., Mills J., Marshall F.J. J. med. Chem. 1963; 6: 343
- Murphy M.J., Dunbar D.A., Kaminsky L.S. Toxic, appl. Pharmac. 1983; 71: 84
- Omura T., Sato R. J. biol. Chem. 1964; 239: 2370
- Schenkman J.B., Kupfer D. Hepatic Cytochrome P450 Mono-oxygenase System. Pergamon, Oxford 1982
- Seguchi K., Osawa A. Yukagaku 1982; 31: 609
- Testa B., Jenner P. Drug Metabolism: Chemical and Biochemical Aspects. Marcel Dekker, New York 1976a
- Testa B., Jenner P. J. Pharm. Pharmac. 1976b; 28: 731
- Trager W.F. Concepts in Drug Metabolism, P. Jenner, B. Testa. Marcel Dekker, New York 1980; 177–209, Part A
- Yoshimura H., Tsuji H., Tsukamoto H. Chem. Pharm. Bull. 1966; 14: 939
- Yoshino T., Inaba S., Komura H., Ishido Y. J. chem. Soc. Perkin Trans. I 1977; 1266